Irgm1 regulates metabolism and function in T cell subsets

Area of Science:

• Immunology
• Cell Biology
• Molecular Genetics

Background:

• Immunity Related GTPases (IRG) are key regulators of cellular membrane remodeling during infection.
• The human IRGM gene is linked to inflammatory diseases like Crohn's disease.
• Previous research highlighted IRGM/Irgm1's role in macrophage function.

Purpose of the Study:

• To investigate the role of Irgm1 in the function of mature T cells.
• To understand how Irgm1 deficiency impacts T cell subsets and their functions.

Main Methods:

• Analysis of T cell populations in mice lacking Irgm1 globally or specifically in T cells.
• Assessment of T cell numbers, apoptosis, and function across different T cell subsets (CD4+, CD8+).
• Metabolic profiling of Irgm1-deficient T cells, including glucose metabolism and glycolysis.
• Treatment of deficient T cells with glycolytic inhibitors to observe functional restoration.

Main Results:

• Irgm1 is highly expressed in T cells, increasing with activation.
• Irgm1-deficient mice showed significant alterations in T cell numbers and function across CD4+ and CD8+ subsets.
• Increased apoptosis was observed in Irgm1-deficient CD4+ and CD8+ T cells.
• Elevated glucose metabolism and glycolysis were identified as key drivers of T cell dysfunction.
• Inhibition of glycolysis partially restored T cell function and viability in Irgm1-deficient cells.

Conclusions:

• Irgm1 plays a critical role in regulating T cell homeostasis and function.
• Altered T cell metabolism, particularly increased glycolysis, is a major consequence of Irgm1 deficiency.
• Targeting T cell metabolism may offer therapeutic potential for Irgm1-related immune dysregulation.